| 04.08.2021 14:00 | STX | Price Monitoring Extension | RNS |
| 23.06.2021 16:40 | STX | Second Price Monitoring Extn | RNS |
| 23.06.2021 16:35 | STX | Price Monitoring Extension | RNS |
| 21.06.2021 13:35 | STX | Investor presentation | Reach |
| 18.06.2021 07:00 | STX | Directorate Change | RNS |
| 17.06.2021 14:30 | STX | Results of 2021 Annual General Meeting | RNS |
| 15.06.2021 18:15 | STX | Grant of share options to the CEO | RNS |
| 28.05.2021 07:00 | STX | Appointment of new Chief Executive Officer | RNS |
| 28.05.2021 07:00 | STX | Total Voting Rights | RNS |
| 26.05.2021 10:35 | STX | Hardman & Co Research: Shield Therapeutics (STX): Accrufer launch on schedule | EQS |
| 21.05.2021 07:00 | STX | US update | RNS |
| 18.05.2021 07:00 | STX | AEGIS-H2H study results published in IBD | Reach |
| 17.05.2021 07:00 | STX | Commencement of trading on the OTCQX Best Market | RNS |
| 13.05.2021 15:00 | STX | 2020 Annual Report and 2021 AGM Notice | RNS |
| 10.05.2021 07:00 | STX | Appointment of Two Non-Executive Directors | RNS |
| 06.05.2021 13:44 | STX | Total Voting Rights Update | RNS |
| 29.04.2021 07:00 | STX | Preliminary Results | RNS |
| 22.04.2021 07:00 | STX | Notice of Results | RNS |
| 07.04.2021 09:33 | STX | Holding(s) in Company | RNS |
| 07.04.2021 09:31 | STX | Holding(s) in Company | RNS |
| 06.04.2021 11:05 | STX | Second Price Monitoring Extn | RNS |
| 06.04.2021 11:00 | STX | Price Monitoring Extension | RNS |
| 06.04.2021 07:00 | STX | Holding(s) in Company | RNS |
| 31.03.2021 15:01 | STX | Total Voting Rights Update | RNS |
| 31.03.2021 15:00 | STX | Block Listing 6 Monthly Return | RNS |
| 30.03.2021 07:00 | STX | Investor presentation | Reach |
| 24.03.2021 17:40 | STX | Block Listing Application | RNS |
| 23.03.2021 17:53 | STX | Holding(s) in Company | RNS |
| 23.03.2021 12:23 | JUP, STX | Holding(s) in Company | RNS |
| 22.03.2021 07:00 | STX | Shield appoints new Chief Financial Officer | RNS |
| 18.03.2021 14:02 | STX | Result of General Meeting & Open Offer | RNS |
| 15.03.2021 17:21 | STX | Holding(s) in Company | RNS |
| 09.03.2021 07:00 | STX | Australia's TGA approves Feraccru | RNS |
| 05.03.2021 16:54 | STX | PDMR Transaction Notification | RNS |
| 04.03.2021 18:17 | STX | PDMR/PCA Transaction Notification | RNS |
| 03.03.2021 13:40 | STX | Investor Presentation | RNS |
| 01.03.2021 07:00 | STX | Publication of Circular and Notice of GM | RNS |
| 26.02.2021 16:09 | STX | Successful completion of £25 million Fundraise | RNS |
| 26.02.2021 12:30 | STX | Total Voting Rights Update | RNS |
| 26.02.2021 11:05 | STX | Second Price Monitoring Extn | RNS |
| 26.02.2021 11:00 | STX | Price Monitoring Extension | RNS |
| 26.02.2021 09:30 | STX | Placing and Subscription to raise up to £25m | RNS |
| 19.02.2021 11:05 | STX | Second Price Monitoring Extn | RNS |
| 19.02.2021 11:00 | STX | Price Monitoring Extension | RNS |
| 02.02.2021 08:00 | STX | Edison Investment Research Limited: Shield Therapeutics (STX): Beefing up for the US opportunity | EQS |
| 29.01.2021 14:38 | STX | Shareholder loan facilities | RNS |
| 29.01.2021 07:00 | STX | Total Voting Rights Update | RNS |
| 21.01.2021 17:41 | STX | Director/PDMR Shareholding | RNS |
| 19.01.2021 14:20 | STX | Director/PDMR Shareholding | RNS |
| 15.01.2021 10:00 | STX | Investor presentation | Reach |
| 15.01.2021 07:00 | STX | Business and trading update | RNS |
| 14.01.2021 11:05 | STX | Second Price Monitoring Extn | RNS |
| 14.01.2021 11:00 | STX | Price Monitoring Extension | RNS |
| 06.01.2021 07:15 | STX | Hardman & Co Research: Shield Therapeutics (STX): Reassessing the US opportunity | EQS |
